Pfizer signs a deal with Allogene to develop a cancer cell therapy – CNBC
CNBC |
Pfizer signs a deal with Allogene to develop a cancer cell therapy
CNBC Pfizer said on Tuesday it signed an agreement with Allogene Therapeutics, a company formed by a consortium in which the drugmaker will hold a 25 percent stake, to further develop its allogenic CAR T cell therapy. The agreement will accelerate the … Pfizer signs deal with Allogene to develop cancer cell therapy Kite founder's new firm inks off-the-shelf CAR T deal with Pfizer Pfizer and Allogene Therapeutics Enter into Asset Contribution Agreement for Pfizer's Allogeneic CAR T Immuno … |
